Sign on San Diego -- The San Diego biotech company Vical said shareholder Special Situations Funds agreed to invest $4.6 million for 2 million shares and options to buy an additional 1 million shares. Last week, the company announced agreements with Federated Kaufman Fund and another institutional investor under which they would buy $15.4 million in securities.
